Abstract BACKGROUND Aside from surgery, radiotherapy (RT) remains the only standard of care treatment for meningiomas. However, few studies have identified clinical/molecular biomarkers associated with responsiveness to RT and optimal timing after surgery controversial. We aimed assess outcomes in a large multi-institutional cohort RT-treated meningiomas identify clinical factors DNA methylatio...
